Aarti K Rao1, Roy Soetikno1, Gottumukkala S Raju2, Phillip Lum2, Robert V Rouse1, Tohru Sato1, Diane Titzer-Schwarzl1, James Aisenberg3, Tonya Kaltenbach4. 1. Veterans Affairs Palo Alto Health Care System and Stanford University School of Medicine, Palo Alto, California. 2. The University of Texas MD Anderson Cancer Center, Houston, Texas. 3. Icahn School of Medicine at Mount Sinai, New York, New York. 4. Veterans Affairs Palo Alto Health Care System and Stanford University School of Medicine, Palo Alto, California. Electronic address: endoresection@me.com.
Abstract
BACKGROUND & AIMS: As many as 50% of large sessile serrated adenomas/polyps (SSPs) are removed incompletely, which is significant because SSPs have been implicated in the development of interval cancers. It is unclear if endoscopic mucosal resection (EMR) is an optimal method for removal of SSPs. We assessed the efficacy and safety of removal of SSPs 10 mm and larger using a standardized inject-and-cut EMR technique. METHODS: We performed a retrospective analysis of colonoscopy data, collected over 7 years (2007-2013) at 2 centers, from 199 patients with proximal colon SSPs 10 mm and larger (251 polyps) removed by EMR by 4 endoscopists. The primary outcome measure was local recurrence. The secondary outcome measure was safety. RESULTS: At the index colonoscopy, patients had a median of 1 serrated lesion (range, 1-12) and 1 nonserrated neoplastic lesion (range, 0-15). The mean SSP size was 15.9 ± 5.3 mm; most were superficially elevated (84.5%) and located in the ascending colon (51%), and 3 SSPs (1.2%) had dysplasia. Surveillance colonoscopies were performed on 138 patients (69.3%) over a mean follow-up period of 25.5 ± 17.4 months. Of these patients, 5 had local recurrences (3.6%; 95% confidence interval, 0.5%-6.7%), detected after 17.8 ± 15.4 months, with a median size of 4 mm. No patients developed postprocedural bleeding, perforation, or advanced colon cancer, or had a death related to the index colorectal lesion during the study period. CONCLUSIONS: Inject-and-cut EMR is a safe and effective technique for the resection of SSPs. Less than 5% of patients have a local recurrence, which is usually small and can be treated endoscopically.
BACKGROUND & AIMS: As many as 50% of large sessile serrated adenomas/polyps (SSPs) are removed incompletely, which is significant because SSPs have been implicated in the development of interval cancers. It is unclear if endoscopic mucosal resection (EMR) is an optimal method for removal of SSPs. We assessed the efficacy and safety of removal of SSPs 10 mm and larger using a standardized inject-and-cut EMR technique. METHODS: We performed a retrospective analysis of colonoscopy data, collected over 7 years (2007-2013) at 2 centers, from 199 patients with proximal colon SSPs 10 mm and larger (251 polyps) removed by EMR by 4 endoscopists. The primary outcome measure was local recurrence. The secondary outcome measure was safety. RESULTS: At the index colonoscopy, patients had a median of 1 serrated lesion (range, 1-12) and 1 nonserrated neoplastic lesion (range, 0-15). The mean SSP size was 15.9 ± 5.3 mm; most were superficially elevated (84.5%) and located in the ascending colon (51%), and 3 SSPs (1.2%) had dysplasia. Surveillance colonoscopies were performed on 138 patients (69.3%) over a mean follow-up period of 25.5 ± 17.4 months. Of these patients, 5 had local recurrences (3.6%; 95% confidence interval, 0.5%-6.7%), detected after 17.8 ± 15.4 months, with a median size of 4 mm. No patients developed postprocedural bleeding, perforation, or advanced colon cancer, or had a death related to the index colorectal lesion during the study period. CONCLUSIONS: Inject-and-cut EMR is a safe and effective technique for the resection of SSPs. Less than 5% of patients have a local recurrence, which is usually small and can be treated endoscopically.
Authors: Anne F Peery; Katherine S Cools; Paula D Strassle; Sarah K McGill; Seth D Crockett; Aubrey Barker; Mark Koruda; Ian S Grimm Journal: Gastroenterology Date: 2018-01-06 Impact factor: 22.682
Authors: Anne F Peery; Nicholas J Shaheen; Katherine S Cools; Todd H Baron; Mark Koruda; Joseph A Galanko; Ian S Grimm Journal: Gastrointest Endosc Date: 2017-04-10 Impact factor: 9.427
Authors: Amol Agarwal; Sidyarth Garimall; Frank I Scott; Nuzhat A Ahmad; Michael L Kochman; Gregory G Ginsberg; Vinay Chandrasekhara Journal: Surg Endosc Date: 2017-09-22 Impact factor: 4.584
Authors: Arnaldo Amato; Franco Radaelli; Loredana Correale; Emilio Di Giulio; Andrea Buda; Vincenzo Cennamo; Lorenzo Fuccio; Massimo Devani; Ottaviano Tarantino; Giancarla Fiori; Germana De Nucci; Mario De Bellis; Cesare Hassan; Alessandro Repici Journal: United European Gastroenterol J Date: 2019-09-23 Impact factor: 4.623
Authors: Asim Alam; Christopher Ma; Sheng-Fang Jiang; Christopher D Jensen; Kenneth H Webb; Eshandeep S Boparai; Terry L Jue; Craig A Munroe; Suraj Gupta; Jeffrey Fox; Christopher M Hamerski; Fernando S Velayos; Douglas A Corley; Jeffrey K Lee Journal: Clin Transl Gastroenterol Date: 2022-05-01 Impact factor: 4.396